Vanda Pharmaceuticals (VNDA) Other Non-Current Assets (2009 - 2015)
Vanda Pharmaceuticals (VNDA) reported Other Assets of $813,000 for Q3 2015, up 3.6% from $785,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Vanda Pharmaceuticals (VNDA) Other Non-Current Assets (2009 - 2015) Analysis & Trends
Dating back to Q4 2010, Vanda Pharmaceuticals' Other Assets record includes 19 quarters.
- Other Assets has a four-year compound annual growth rate of 17.3% (FY2010 to FY2014).
- By year, Other Assets came in at $500,000 in FY2013 (-16.7%), $600,000 in FY2012 (unchanged), $600,000 in FY2011 (+39.5%) and $430,000 in FY2010.
- Five-year quarterly Other Assets spans a low of $430,000 in Q4 2010 and a high of $1.11 million in Q1 2012.
- Year over year, Other Assets has now increased in each of the last seven quarters, with growth averaging 21.9% over the last eight quarters.
- The high point for year-over-year Other Assets in five years was Q2 2012 (growth of 94.3%); the low point was Q3 2012 (a decline of 46.1%).
- Per Business Quant data, the three quarters before Q3 2015 came in at $813,000 (Q2 2015), $813,000 (Q1 2015) and $813,000 (Q4 2014).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Vanda Pharmaceuticals | 246.71 Mn | -529.97 Mn | 65.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 813,000.00 |
| Jun 30, 2015 | 813,000.00 |
| Mar 31, 2015 | 813,000.00 |
| Dec 31, 2014 | 813,000.00 |
| Sep 30, 2014 | 785,000.00 |
| Jun 30, 2014 | 785,000.00 |
| Mar 31, 2014 | 785,000.00 |
| Dec 31, 2013 | 500,000.00 |
| Sep 30, 2013 | 500,000.00 |
| Jun 30, 2013 | 600,000.00 |
| Mar 31, 2013 | 600,000.00 |
| Dec 31, 2012 | 600,000.00 |
| Sep 30, 2012 | 600,000.00 |
| Jun 30, 2012 | 1.03 Mn |
| Mar 31, 2012 | 1.11 Mn |
| Dec 31, 2011 | 600,000.00 |
| Sep 30, 2011 | 1.11 Mn |
| Jun 30, 2011 | 530,000.00 |
| Mar 31, 2011 | 430,000.00 |
| Dec 31, 2010 | 430,000.00 |
API Access
Vanda Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();